期刊文献+

去甲肾上腺素转运体基因启动子多态性及单倍体型与高血压病血瘀证的相关性研究 被引量:6

Relationship between Gene Polymorphism and Haplotype of SLC6A2 Promoter and Blood-stasis Pattern in Patients with Essential Hypertension
下载PDF
导出
摘要 目的探讨去甲肾上腺素转运体(SLC6A2)基因启动子2、3多态性及单倍体型与高血压病血瘀证的关系。方法收集高血压病血瘀证患者532例,高血压病非血瘀证患者298例,血压正常对照者512名,采外周静脉血提取DNA,采用PCR-RFLP法检测SLC6A2基因启动子2、3多态性,SHEsis软件构建单倍体数量。结果χ2分割显示高血压病血瘀证组的启动子2-GG频率低于非血瘀证组和对照组(P=0.001),重度血瘀组的启动子3-GG/GA频率高于其余组别(P<0.001)。Logistic回归分析显示,调整混杂因素后,启动子2-GC/CC型患高血压病血瘀证的相对危险度(OR)为1.535(95%CI:1.094~2.155,P=0.013);启动子3-AG/GG型患高血压病重度血瘀证的OR为1.925(95%CI:1.199~3.091,P=0.007);G-C单倍体(启动子3-2)患高血压病血瘀证的OR为2.127(95%CI:1.202~3.765,P=0.010),预测强度最大。结论携带SLC6A2基因启动子3-AG/GG型可能是高血压病重度血瘀证易患基因,启动子2-GC/GC、G-C单倍体可能是血瘀证易患因素之一。 Objective To explore the relationship between the genetic variants of the norepinephrine transporter gene solute carrier family 6 member 2 (SLC6A2) and blood stasis pattern (BSP) in patients with essential hypertension (EH). Methods DNA was extracted from the peripheral blood of 830 EH patients (532 were typed as BSP and 298 as non-BSS) and 512 persons with normal blood pressure (for control), to detect the polymorphisms of SLC6A2 promoter-3 and 2 by PCR-RFLP, and estimate the haplotype frequency adopting SHEsis program. Results χ2 partition showed that frequency of promoter-2-GG genotype in EH patients of BSP was lower than that in the EH patients of non-BSP and the normal control (P=0.001); while that of promoter-3-GG/GA in the EH patients with severe BSP was the highest (P0.001). Logistic regression analysis showed that after the miscellaneous factors being rectified, with the reference category of EH-non-BSP, the relative odds ratio (OR) of promoter-2-GC/CC genotype for EH-BSP was 1.535 (95%CI: 1.094-2.155, P=0.013); that of promoter-3-AG/GG genotype for EH with severe BSP was 1.925 (95%CI: 1.199-3.091, P=0.007); while OR of G-C haplotype (promoter-3-promoter-2) for EH-BSP was 2.127 (95%CI: 1.202-3.765, P=0.010), showing the strongest intensity.Conclusion SLC6A2 promoter-3-GA/GG genotype may be a susceptibility gene for patients of EH with severe BSP; promoter2-GC/CC and G-C haplotype might be the susceptible factors to EH-BSP.
出处 《中国中西医结合杂志》 CAS CSCD 北大核心 2010年第5期458-462,共5页 Chinese Journal of Integrated Traditional and Western Medicine
基金 福建省自然科学基金资助项目(No.2008J0322) 福建省青年科技人才创新项目(No.2008F3025)
关键词 基因多态性 高血压病 血瘀证 去甲肾上腺素转运体 单倍体型 gene polymorphism hypertension blood-stasis pattern norepinephrine transporter haplotype
  • 相关文献

二级参考文献90

  • 1刘旭东,李锦毅,史晶,李贺.去甲肾上腺素转运蛋白的研究进展[J].武警医学,2005,16(4):294-296. 被引量:9
  • 2任占利,郭蓉娟.中风病证候诊断标准的研究[J].北京中医药大学学报,1996,19(4):49-50. 被引量:40
  • 3中西医结合杂志社.微观辩证与辩证微观化[J].中西医结合杂志,1987,7(5):263-263.
  • 4赖世隆 曹桂婵 等.中医证候的数理统计基础及血瘀证宏观辩证计量化初探[J].中国医药学报,1988,3(6):27-27.
  • 5王阶 陈可冀 等.血瘀证诊断标准的研究[J].中西医结合杂志,1988,8(10):585-585.
  • 6细野八郎.日本的瘀血研究情况[J].实用中西医结合杂志,1989,2(1):16-16.
  • 7寺泽捷年.瘀血证的证候分析与诊断标准刍议[J].国外医学:中医中药分册,1984,(1):1-1.
  • 8中岛一.从皮肤病学角度探讨血瘀证的诊断标准[J].中西医结合杂志,1988,8(10):588-588.
  • 9小川新.国际瘀血证诊断标准草案[J].第一届中日血瘀证综合研究会议论文摘要,1992,:4-4.
  • 10孟家遐 梁宝华 等.脑血管病临床辩证规范化定量化初探[J].中西医结合杂志,1988,8(3):173-173.

共引文献393

同被引文献120

引证文献6

二级引证文献75

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部